CN101717446B - 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 - Google Patents
抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 Download PDFInfo
- Publication number
- CN101717446B CN101717446B CN2009101538970A CN200910153897A CN101717446B CN 101717446 B CN101717446 B CN 101717446B CN 2009101538970 A CN2009101538970 A CN 2009101538970A CN 200910153897 A CN200910153897 A CN 200910153897A CN 101717446 B CN101717446 B CN 101717446B
- Authority
- CN
- China
- Prior art keywords
- prrsv
- antibody
- yolk
- protein
- igy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title abstract description 26
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 239000000427 antigen Substances 0.000 claims abstract description 9
- 102000036639 antigens Human genes 0.000 claims abstract description 9
- 108091007433 antigens Proteins 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 19
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 238000001262 western blot Methods 0.000 claims description 8
- 238000012870 ammonium sulfate precipitation Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 5
- 238000003113 dilution method Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 238000009010 Bradford assay Methods 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 230000005847 immunogenicity Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 230000009465 prokaryotic expression Effects 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 230000008021 deposition Effects 0.000 claims description 3
- 238000010612 desalination reaction Methods 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 230000002163 immunogen Effects 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 210000001534 vitelline membrane Anatomy 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 241000700605 Viruses Species 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 6
- 241000124008 Mammalia Species 0.000 abstract description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 5
- 230000007423 decrease Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 230000000704 physical effect Effects 0.000 abstract description 2
- 102000009109 Fc receptors Human genes 0.000 abstract 1
- 108010087819 Fc receptors Proteins 0.000 abstract 1
- 102000006395 Globulins Human genes 0.000 abstract 1
- 108010044091 Globulins Proteins 0.000 abstract 1
- 206010029719 Nonspecific reaction Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 18
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000010166 immunofluorescence Methods 0.000 description 8
- 102100034613 Annexin A2 Human genes 0.000 description 7
- 108090000668 Annexin A2 Proteins 0.000 description 7
- 235000020183 skimmed milk Nutrition 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 101710141454 Nucleoprotein Proteins 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical class C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 101150001779 ORF1a gene Proteins 0.000 description 1
- 101710087110 ORF6 protein Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 102100021696 Syncytin-1 Human genes 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 241000710914 Totivirus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 1
- 210000002718 aborted fetus Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101538970A CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101538970A CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101717446A CN101717446A (zh) | 2010-06-02 |
CN101717446B true CN101717446B (zh) | 2012-03-14 |
Family
ID=42432089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101538970A Expired - Fee Related CN101717446B (zh) | 2009-11-17 | 2009-11-17 | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101717446B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101915846A (zh) * | 2010-08-13 | 2010-12-15 | 扬州大学 | 检测猪繁殖与呼吸综合征病毒的elisa试剂盒及使用方法 |
CN102977184B (zh) * | 2012-11-13 | 2014-07-09 | 天津耀宇生物技术有限公司 | 家蚕蚕蛹中30kD蛋白群的纯化方法 |
CN103421832B (zh) * | 2012-12-04 | 2015-09-09 | 武汉市畜牧兽医科学研究所 | 包含氟苯尼考耐药基因蛋白的卵黄抗体及制备与应用 |
CN103694348A (zh) * | 2013-12-10 | 2014-04-02 | 刘聚祥 | 一种治疗猪病毒性腹泻生物制剂的制备和应用方法 |
CN104277107A (zh) * | 2014-10-11 | 2015-01-14 | 中国农业大学 | 一种沃尼妙林卵黄抗体的制备方法 |
CN105906713B (zh) * | 2016-04-01 | 2019-08-16 | 南阳师范学院 | 一种猪elf4蛋白卵黄抗体的制备方法 |
CN109182364A (zh) * | 2018-08-30 | 2019-01-11 | 武汉百意欣生物技术有限公司 | 一种特异性识别蛋白a的多克隆抗体及其制备方法和应用 |
CN109557316A (zh) * | 2018-12-03 | 2019-04-02 | 湖北省农业科学院畜牧兽医研究所 | 一种鸭坦布苏卵黄抗体的检测方法 |
CN111471104B (zh) * | 2020-04-29 | 2022-03-25 | 西北农林科技大学 | 一种prrsv广谱中和单克隆抗体及其应用 |
CN111500598A (zh) * | 2020-05-08 | 2020-08-07 | 华南农业大学 | 一种检测欧洲型prrsv抗体效价的试剂盒及检测方法 |
CN111579795B (zh) * | 2020-05-15 | 2023-03-31 | 安徽中起生物科技有限公司 | 猪蓝耳病毒GP5蛋白IgY抗体检测免疫荧光试纸及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060153855A1 (en) * | 2002-10-30 | 2006-07-13 | Garzon Jose A M | Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS) |
CN101184997A (zh) * | 2005-02-25 | 2008-05-21 | 艾德克斯实验室公司 | 用于检测抗猪繁殖呼吸综合征病毒抗体的肽 |
-
2009
- 2009-11-17 CN CN2009101538970A patent/CN101717446B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060153855A1 (en) * | 2002-10-30 | 2006-07-13 | Garzon Jose A M | Prevention and treatment of the porcine reproductive and respiratory syndrome (PRRS) |
CN101184997A (zh) * | 2005-02-25 | 2008-05-21 | 艾德克斯实验室公司 | 用于检测抗猪繁殖呼吸综合征病毒抗体的肽 |
WO2007061281A2 (es) * | 2005-11-23 | 2007-05-31 | Investigación Aplicada, S.A. De C.V. | Prevención y tratamiento del sindrome respiratorio y reproductivo del cerdo (prrs) |
Also Published As
Publication number | Publication date |
---|---|
CN101717446A (zh) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101717446B (zh) | 抗PRRSV-N-IgY抗体的制备及在检测PRRSV中的应用 | |
Oleksiewicz et al. | Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes | |
CN101661042B (zh) | 猪繁殖与呼吸综合征病毒双抗体夹心elisa试剂盒 | |
KR20010012337A (ko) | 백신 또는 진단방법에서 사용하기 위한 피알알에스바이러스의 피알알에스브이 항원부위 인식성 펩타이드 서열 | |
Liu et al. | Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus | |
CN110004178A (zh) | 一种牛病毒性腹泻病毒样颗粒的制备的制备方法 | |
Ren et al. | Heterologous expression of fused genes encoding the glycoprotein 5 from PRRSV: a way for producing functional protein in prokaryotic microorganism | |
Jiménez de Oya et al. | Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses | |
CN103555680A (zh) | 一种具有免疫原性的prrsv病毒样颗粒及其制备与应用 | |
Wang et al. | Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera | |
Sun et al. | Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains | |
CN105348386B (zh) | 抗口蹄疫o型病毒的单克隆抗体组合及检测试剂盒 | |
Meng et al. | Production and characterization of a monoclonal antibody against spike protein of transmissible gastroenteritis virus | |
CN108559754B (zh) | 一种猪繁殖与呼吸综合征病毒gp5基因修饰的重组蛋白及其应用 | |
Masuda et al. | Stable trimer formation of spike protein from porcine epidemic diarrhea virus improves the efficiency of secretory production in silkworms and induces neutralizing antibodies in mice | |
Gómez et al. | Development of diagnostic tools for IBDV detection using plants as bioreactors | |
CN105968175A (zh) | 一种重组小反刍兽疫病毒n蛋白及其表达方法和应用 | |
CN109959788A (zh) | 一种用于检测猪伪狂犬病病毒gE抗体的包被抗原和酶标抗体及阻断法试剂盒 | |
JPH05509225A (ja) | C型ロタウイルス培養体およびその利用法 | |
CN105296435B (zh) | 杂交瘤细胞株及其分泌的抗口蹄疫o型(o/gx/09-7)病毒的特异性单克隆抗体与应用 | |
CN1477108A (zh) | 重组gE蛋白及其在诊断伪狂犬病毒感染中的应用 | |
Go et al. | Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test | |
CN109554375A (zh) | 美洲型prrsv n蛋白抗原表位及其应用 | |
US20230285534A1 (en) | Viral vaccine compositions and methods of preparations thereof | |
CN103882051A (zh) | 一种检测猪瘟病毒抗体的elisa方法及检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiaoliang Inventor after: Fang Weihuan Inventor after: Wan Xiaoyuan Inventor before: Li Xiaoliang Inventor before: Fang Weihuan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI XIAOLIANG FANG WEIHUAN TO: LI XIAOLIANG FANG WEIHUAN WAN XIAOYUAN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20100602 Assignee: HANGZHOU JIANLIANG VETERINARY BIOLOGICAL PREPARATIONS CO., LTD. Assignor: Zhejiang University Contract record no.: 2013330000373 Denomination of invention: Preparation for PRRSV-N-IgY antibody and application thereof in detecting PRRSV Granted publication date: 20120314 License type: Exclusive License Record date: 20131213 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120314 Termination date: 20151117 |
|
EXPY | Termination of patent right or utility model |